๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 276 Beijing 6 Hangzhou 5 Wuhan 5 Qionghai 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84 Clear sponsor filter
Site location
Shanghai276 Beijing6 Hangzhou5 Wuhan5 Qionghai5
All 38 locations
Target enrolment
to
276 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06972641AML, MDS
Ruijin Hospital
Phase 2/3
126
Shanghai
2025-06-10
Recruiting
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
NCT07026149Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2
30
Shanghai
2025-06-08
Recruiting
IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
NCT07025889Gastric Cancer
Ruijin Hospital
Phase 1/2
55
Shanghai
2025-06-02
Recruiting
Adjuvant Pancreatic Therapy Guided by MRD
NCT06966440Pancreatic Adenocarcinoma Resectable
Ruijin Hospital
Not applicable
856
Shanghai
2025-06-01
By invitation
Comparison of MIPPED-C and Surgical Necrosectomy in Pancreatic Necrosis Outcomes
NCT07097753Acute Pancreatitis (AP), Acute Pancreatitis With Infected Necrosis
Ruijin Hospital
Observational
144
Shanghai
2025-06-01
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT07072169B-cell Non-Hodgkin Lymphoma
Ruijin Hospital
Phase 1
56
Shanghai
2025-05-26
Recruiting
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
NCT07080021Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Ruijin Hospital
Observational
119
Shanghai
2025-05-20
Recruiting
A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease
NCT06992661Interstitial Lung Disease (ILD), Healthy Volunteers
Ruijin Hospital
Phase 1
84
Shanghai
2025-05-15
Not yet open
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
NCT06943690Rectal Cancer, Surgery
Ruijin Hospital
Not applicable
212
Luoyang, Jinan, Shanghai, Wenzhou
2025-05
Not yet open
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma
NCT06935136CAR-T Cell Therapy, High-risk Large B-cell Lymphoma (LBCL)
Ruijin Hospital
Not applicable
60
Shanghai
2025-04-30
Recruiting
Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE๏ผ‰
NCT07004634Esophageal Cancer, Drainage/Methods, Postoperative Pain
Ruijin Hospital
Not applicable
75
Shanghai
2025-04-30
Recruiting
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
NCT06818084AORTIC VALVE DISEASES, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR)
Ruijin Hospital
Phase 4
120
Shanghai
2025-04-29
By invitation
Intrapatient Comparison of STN and GPi tTIS in PD
NCT07018388Parkinson Disease
Ruijin Hospital
Not applicable
100
Shanghai
2025-04-23
Recruiting
18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients
NCT07004673Carotid Artery Plaque, Ischemic Stroke, PET / MR
Ruijin Hospital
Observational
100
Shanghai
2025-04-12
Recruiting
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
NCT07353463Parkinson's Disease (PD), Multiple System Atrophy
Ruijin Hospital
Observational
700
Shanghai
2025-04-01
Recruiting
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL
NCT06803693Diffuse Large B-Cell Lymphoma
Ruijin Hospital
Phase 2
152
Shanghai
2025-04-01
Not yet open
The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults
NCT06876701Acute Leukemia
Ruijin Hospital
Phase EARLY_PHASE1
10
Shanghai
2025-04-01
Not yet open
Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma
NCT06788600Epstein-Barr Virus Associated Lymphoma
Ruijin Hospital
Observational
15
Shanghai
2025-04-01
Not yet open
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037Gastric Adenocarcinoma, GEJ Adenocarcinoma, First-line Therapy, Maintenance Therapy
Ruijin Hospital
Phase 2
55
Shanghai
2025-03-31
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
NCT06946953Chronic Obstructive Pulmonary Disease (COPD)
Ruijin Hospital
Phase 1/2
20
Qionghai, Shanghai
2025-03-23
By invitation
Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in Allo-HSCT Patients
NCT06912347Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital
Not applicable
180
Shanghai
2025-03-18
Recruiting
MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors
NCT07004647Peritoneal Tumor
Ruijin Hospital
Not applicable
10
Shanghai
2025-03-15
Recruiting
Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension
NCT06829134Hypertension, Retroperitoneal Disease
Ruijin Hospital
Not applicable
246
Shanghai
2025-03-01
Not yet open
The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
NCT06863441T-NK Cell Lymphoma
Ruijin Hospital
Observational
50
Shanghai
2025-03-01
Active, closed
High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis
NCT06897384Severe Acute Pancreatitis
Ruijin Hospital
Not applicable
388
Shanghai
2025-03-01
Recruiting
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
NCT06519591Gastric Cancer Stage IV, Peritoneal Metastases
Ruijin Hospital
Phase 2
40
Shanghai
2025-02-25
Recruiting
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580Oral Microbiota, Pancreatitis, Pancreatic Cancer
Ruijin Hospital
Observational
360
Shanghai
2025-02-18
Recruiting
Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection
NCT06821451Lung Nodules
Ruijin Hospital
Not applicable
80
Shanghai
2025-02-10
Recruiting
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
NCT06796725Migraine Disorders, Brain, rTMS Stimulation
Ruijin Hospital
Not applicable
60
Shanghai
2025-02-06
Recruiting
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
NCT06601075Advanced Colorectal Cancer
Ruijin Hospital
Observational
30
Shanghai
2025-02-01
Recruiting
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
NCT06800768Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2025-02-01
Not yet open
Avapritinib Maintenance for AML With KIT Mutations
NCT06765915AML, Adult
Ruijin Hospital
Phase 2
47
Shanghai
2025-02-01
Active, closed
A Study on the Changes and Prognosis of Intestinal Microbiota and Function in Infants With Food Allergies
NCT06854536Health, Children, Gut Microbiota
Ruijin Hospital
Observational
100
Shanghai
2025-02-01
Recruiting
MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL
NCT06793189Marginal Zone Lymphoma(MZL)
Ruijin Hospital
Phase 2
145
Shanghai, Shenyang, Beijing
2025-01-23
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses
NCT06693362Severe Viral Pneumonia(Not Include COVID-19)
Ruijin Hospital
Phase 1
60
Shanghai
2025-01-20
Recruiting
A Study of Chinese Congenital Bicuspid Aortic Valve
NCT06802016Bicuspid Aortic Valve (BAV)
Ruijin Hospital
Observational
500
Shanghai
2025-01-18
Not yet open
Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
NCT06765928MDS, AML, Adult
Ruijin Hospital
Phase 2
73
Shanghai
2025-01-01
Active, closed
Electrical Impedance Tomography-Based Dynamic Ventilation-Perfusion Functional Phenotype Trajectory in Acute Respiratory Distress Syndrome
NCT07370610ARDS, Mechanically Ventilated Patients
Ruijin Hospital
Observational
120
Shanghai
2025-01-01
Recruiting
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
NCT06779435DLBCL
Ruijin Hospital
Observational
400
Shanghai
2025-01-01
Not yet open
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299T-NK Cell Lymphoma
Ruijin Hospital
Observational
200
Shanghai
2025-01-01
Recruiting
Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer
NCT07035002Colorectal Cancer (CRC), Tumor Infiltrating Lymphocytes, PD-1
Ruijin Hospital
Phase 1
29
Shanghai
2024-12-31
Not yet open
CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)
NCT06750991DLBCL
Ruijin Hospital
Phase 2
34
Shanghai
2024-12-31
Recruiting
Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Lesions With Rapid Staining of Cytological Smears Followed by Whole Slide Scanning and Artificial Intelligence Diagnosis: A Prospective, Multicenter Study.
NCT06824909Pancreatic Disease
Ruijin Hospital
Observational
1,500
Shanghai
2024-12-31
Active, closed
A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT07461181Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital
Phase 1/2
10
Shanghai
2024-12-30
Recruiting
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217Non-Small Cell Lung Cancer
Ruijin Hospital
Observational
40
Shanghai
2024-12-30
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
NCT06747156Autoimmune Diseases
Ruijin Hospital
Phase EARLY_PHASE1
66
Wuhan, Nanjing, Shanghai
2024-12-23
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
NCT06718244Acute Lymphoblastic Leukemia
Ruijin Hospital
Phase 2
20
Shanghai
2024-12-10
Recruiting
CR-CHOP+X in Previously Untreated DEL
NCT06701357DLBCL
Ruijin Hospital
Phase 2
49
Shanghai
2024-12-10
Recruiting
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
NCT06567353Breast Neoplasms, Liver Neoplasms, Metastasis
Ruijin Hospital
Not applicable
10
Shanghai
2024-12-09
Recruiting
Efficacy and Safety of Telitacicept in IgAN
NCT06654596IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept, Glucocorticoid
Ruijin Hospital
Not applicable
118
Shanghai
2024-12-06
Recruiting
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
NCT06746194Hepatocellular Carcinoma (HCC)
Ruijin Hospital
Observational
40
Shanghai
2024-12-03
Recruiting
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
NCT06587061Pancreatic Cancer
Ruijin Hospital
Phase 2
30
Shanghai
2024-12-03
Active, closed
A Study on the Assessment of Difficult Weaning in Patients With Acute Respiratory Failure Undergoing Mechanical Ventilation Based on Machine Learning EIT-pendelluft: A Multicenter Retrospective Study.
NCT06756204Acute Respiratory Failure Requiring Intubation
Ruijin Hospital
Observational
216
Shanghai
2024-12-01
Recruiting
Safety and Efficacy of IMPT or IMRT for Breast Cancer
NCT06826885Breast Cancer, Proton Therapy, Intensity Modulated Radiation Therapy, Efficacy and Safety
Ruijin Hospital
Observational
500
Shanghai
2024-12-01
Not yet open
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
NCT06646666B-cell Non Hodgkin Lymphoma
Ruijin Hospital
Phase 2
35
Shanghai
2024-12-01
Not yet open
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
NCT06549335Follicular Lymphoma
Ruijin Hospital
Phase 2
66
Shanghai
2024-12-01
Recruiting
PSA Versus STN DBS for DT
NCT06752434Dystonic Tremor
Ruijin Hospital
Not applicable
20
Shanghai
2024-12
Recruiting
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
NCT06730529Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2024-11-29
Active, closed
Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
NCT06693128Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2
80
Chengdu, Shanghai, Yantai
2024-11-21
Recruiting
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
NCT06695013B-NHL, CART Therapy
Ruijin Hospital
Phase 2
144
Shanghai
2024-11-20
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
NCT06597539Hepatobiliary Malignancy
Ruijin Hospital
Observational
40
Shanghai
2024-11-09
Active, closed
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
NCT06849921Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors, Hematologic Disease
Ruijin Hospital
Not applicable
200
Shanghai
2024-11-07
Not yet open
Quantitative Ultrasound Assessment of Abdominal Cavity Space
NCT06634732Sepsis, MODS, Shock
Ruijin Hospital
Observational
125
Shanghai
2024-11-01
Not yet open
Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06704542ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus, Impaired Fasting Glucose
Ruijin Hospital
Observational
1,000
Zhengzhou, Wuhan, Shanghai, Hangzhou, Tianjin
2024-11
Not yet open
Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia
NCT06652685Acute Myeloid Leukemia (AML)
Ruijin Hospital
Phase 2
218
Shanghai
2024-10-30
Not yet open
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
NCT06656234Diffuse Large B Cell Lymphoma (DLBCL)
Ruijin Hospital
Observational
200
Shanghai
2024-10-30
Recruiting
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
NCT06709690Paediatric Patients
Ruijin Hospital
Observational
35
Shanghai
2024-10-25
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
NCT06644274Gastrointestinal Malignancies
Ruijin Hospital
Observational
40
Shanghai
2024-10-20
Recruiting
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
NCT06458257Acute Myeloid Leukemia
Ruijin Hospital
Observational
50
Shanghai
2024-10-19
Recruiting
Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
NCT06589089Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 2
18
Shanghai
2024-10-15
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
NCT06644287Advanced Soft Tissue Sarcomas
Ruijin Hospital
Observational
40
Shanghai
2024-10-15
Not yet open
Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)
NCT06658561Cold Snare Resection, Hot Snare Resection, Polyps of Colon
Ruijin Hospital
Not applicable
982
Shanghai
2024-10-15
Recruiting
Efficacy and Safety of tACS for Depression: a Multicenter RCT Study
NCT06891326Depression Disorders
Ruijin Hospital
Not applicable
72
Shanghai
2024-10-08
Active, closed
Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer
NCT06583655Breast Cancer Invasive
Ruijin Hospital
Not applicable
205
Shanghai
2024-10-01
By invitation
The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients
NCT06697418Peritoneal Dialysis, Cardiovascular Diseases, Myocardial Infarct, Heart Failure
Ruijin Hospital
Observational
266
Shanghai
2024-10-01
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
NCT06601010Pancreatic Cancer
Ruijin Hospital
Observational
30
Shanghai
2024-09-24
Recruiting
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
NCT06577532Pancreatic Neoplasms, Other Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1
56
Shanghai
2024-09-24
Recruiting
The Efficacy of Allo-HSCT in ND HR-CBF-AML
NCT06458244Acute Myeloid Leukemia
Ruijin Hospital
Observational
90
Shanghai
2024-09-21
Recruiting
Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
NCT06641856Health Personnel
Ruijin Hospital
Observational
300
Shanghai
2024-09-02
Not yet open
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
NCT06567366Large B-cell Lymphoma
Ruijin Hospital
Phase 2
45
Shanghai
2024-09
By invitation
Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke
NCT06551727Stroke, Ischemic
Ruijin Hospital
Not applicable
70
Shanghai
2024-08-15
Recruiting
Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)
NCT06534463Marginal Zone Lymphoma
Ruijin Hospital
Observational
500
Shanghai
2024-08-02
Recruiting
A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
NCT06541340Pancreatic Cancer, Obstructive Jaundice
Ruijin Hospital
Not applicable
360
Shanghai
2024-08-01
Recruiting
The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
NCT06522555Diffuse Large B-Cell Lymphoma
Ruijin Hospital
Phase 3
100
Shanghai
2024-07-29
Recruiting
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
NCT06755775Diffuse Large B-Cell Lymphoma
Ruijin Hospital
Observational
150
Shanghai
2024-07-23
Recruiting
The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer
NCT06623487Carcinoma, Non-Small-Cell Lung, PET / CT, Neoadjuvant Immunotherapy
Ruijin Hospital
Observational
30
Shanghai
2024-07-19
Recruiting
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
NCT06496373Pancreatic Cancer Resectable, Chemotherapy-intolerant
Ruijin Hospital
Phase EARLY_PHASE1
20
Shanghai
2024-07-16
Recruiting
Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
NCT06496308Mantle Cell Lymphoma (MCL)
Ruijin Hospital
Phase 3
78
Shanghai
2024-07-10
By invitation
Real-world Study of Acalabrutinib
NCT06767891Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Ruijin Hospital
Observational
160
Shanghai
2024-07-02
Recruiting
Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IV
NCT06793787Coronary Artery Disease, Coronary Atheroscleroses, Acute Coronary Syndromes (ACS), Chronic Coronary Syndrome
Ruijin Hospital
Observational
200
Shanghai
2024-07-01
Active, closed
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT
NCT06449586Hematologic Malignancy
Ruijin Hospital
Phase 3
250
Wuhan, Shanghai, Hangzhou
2024-07-01
Recruiting
Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III
NCT06793774Coronary Artery Disease, Coronary Atheroscleroses, Acute Coronary Syndromes (ACS)
Ruijin Hospital
Observational
300
Shanghai
2024-07-01
Recruiting
A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma
NCT06494371Hodgkin's Lymphoma, Anaplastic Large Cell Lymphoma
Ruijin Hospital
Phase 1
32
Shanghai
2024-07
Recruiting
Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT06596954Esophageal Squamous Cell Cancer
Ruijin Hospital
Not applicable
212
Shanghai
2024-06-30
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
NCT06608160PET / CT, Lung Carcinoma, Immunotherapy
Ruijin Hospital
Observational
30
Shanghai
2024-06-20
Recruiting
A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence
NCT06468709Type 1 AIP
Ruijin Hospital
Phase 4
86
Shanghai
2024-06-20
Recruiting
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526Peritoneal Metastasis, Gastric Cancer
Ruijin Hospital
Observational
30
Shanghai
2024-06-15
Not yet open
Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR
NCT06297772AML, Adult
Ruijin Hospital
Phase 3
220
Shanghai
2024-06-01
Recruiting
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
NCT06482788Esophagogastric Junction Adenocarcinoma
Ruijin Hospital
Phase 2
26
Shanghai
2024-05-22
Recruiting
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
NCT06541327Lymphoma, Non-Hodgkin
Ruijin Hospital
Observational
1,000
Shanghai
2024-05-15
Rows per page Showing 101–200 of 276
Previous 1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.